A Practical Guide to Immunoassay Method Validation
Ulf Andréasson(Sahlgrenska University Hospital), Charlotte E. Teunissen(Amsterdam Neuroscience), Niels Kruse(Universitätsmedizin Göttingen), Lucilla Parnetti(Ospedale Santa Maria), Linda Josephine Christine van Waalwijk van Doorn(Radboud University Medical Center), Kaj Blennow(Sahlgrenska University Hospital), Luka Kulic(University of Zurich), Davide Chiasserini(University of Perugia), Sebastiaan Engelborghs(Vrije Universiteit Brussel), Piotr Lewczuk(Universitätsklinikum Erlangen), Armand Perret‐Liaudet(Inserm), Tormod Fladby(University of Oslo), Barbara Mroczko(Medical University of Białystok), Eugeen Vanmechelen(ADx NeuroSciences), Henrik Zetterberg(University of Wisconsin–Madison), H. Bea Kuiperij(Radboud University Nijmegen), Bengt Winblad(Karolinska Institutet), Brit Mollenhauer(Paracelsus Elena Klinik Kassel), Şermin Genç(Izmir University), Marleen J.A. Koel‐Simmelink(Amsterdam UMC Location Vrije Universiteit Amsterdam), Marcel M. Verbeek(Radboud University Nijmegen)
Cited by 541
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk
|Nature Genetics|2019|2.5k
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k